Division of Rheumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Avenida Doutor Arnaldo 455, 3 andar sala 3131, Cerqueira César, São Paulo, CEP: 01246-903, Brazil.
Center for Clinical and Epidemiological Research, Hospital Universitario, University of Sao Paulo, São Paulo, Brazil.
Adv Rheumatol. 2022 May 8;62(1):15. doi: 10.1186/s42358-022-00246-3.
Most of the few studies that have established reference ranges for serum uric acid (SUA) have not taken into account factors which may interfere with its levels and followed rigorous laboratory quality standards. The aim of this study was to establish reference ranges for SUA and determine the prevalence of hyperuricemia.
Cross-sectional study including 15,100 participants (all sample) aged 35 to 74 years from baseline data of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a multicentric cohort of volunteer civil servants from five universities and one research institute located in different regions of Brazil. It was established a reference sample excluding participants with factors that directly influence SUA levels: glomerular filtration rate lower than 60 ml/min, excessive alcohol intake, use of diuretics, aspirin, estrogen or urate-lowering therapy. SUA was measured using the uricase method and following rigorous international quality standards. Reference ranges were defined as values between percentiles 2.5 (P2.5) and 97.5 (P97.5) of SUA distribution in the reference sample, stratified by sex. Hyperuricemia was defined as SUA ≥ 7 mg/100 ml in the all sample.
The reference sample was composed of 10,340 individuals (55.3% women, median age 50 years). Reference ranges (P2.5 to P97.5) for SUA were: 4.0 to 9.2 mg/100 ml for men and 2.8 to 6.9 mg/100 ml for women. Sex was a major determinant for SUA levels (median [IQR], mg/100 ml: 6.1 [5.3-7.0] for men versus 4.5 [3.9-5.3] for women, p < 0.001). Higher levels of SUA were found in patients with higher BMI. Higher age had (a modest) influence only for women. The prevalence of hyperuricemia for all sample (N = 15,100) was 31.9% (95% confidence interval [CI] 30.8-33.0%) in men and 4.8% (95% CI 4.3-5.3%) in women.
SUA reference ranges were 4.0 to 9.2 mg/100 ml for men and 2.8 to 6.9 mg/100 ml for women. Prevalence of hyperuricemia was 31.9% in men and 4.8% in women. Updated SUA reference ranges and prevalence of hyperuricemia are higher nowadays and might be used to guide laboratories and the screening for diseases related to SUA.
大多数已建立血清尿酸(SUA)参考范围的少数研究都没有考虑到可能影响其水平的因素,并且没有遵循严格的实验室质量标准。本研究的目的是建立 SUA 的参考范围并确定高尿酸血症的患病率。
这是一项横断面研究,纳入了来自巴西纵向成人健康研究(ELSA-Brasil)基线数据的 15100 名年龄在 35 至 74 岁的参与者(所有样本),该研究是来自巴西五个地区的五所大学和一个研究所的志愿公务员的多中心队列。建立了一个参考样本,排除了直接影响 SUA 水平的因素:肾小球滤过率低于 60ml/min、过度饮酒、使用利尿剂、阿司匹林、雌激素或降低尿酸的治疗。SUA 采用尿酸酶法测量,并遵循严格的国际质量标准。参考范围定义为参考样本中 SUA 分布的第 2.5(P2.5)和第 97.5(P97.5)百分位数之间的值,按性别分层。所有样本中 SUA≥7mg/100ml 定义为高尿酸血症。
参考样本由 10340 名参与者(55.3%为女性,中位年龄为 50 岁)组成。SUA 的参考范围(P2.5 到 P97.5)为:男性 4.0 至 9.2mg/100ml,女性 2.8 至 6.9mg/100ml。性别是 SUA 水平的主要决定因素(中位数[IQR],mg/100ml:男性为 6.1[5.3-7.0],女性为 4.5[3.9-5.3],p<0.001)。较高的 BMI 与较高的 SUA 水平相关。年龄较高仅对女性有适度影响。所有样本(n=15100)的高尿酸血症患病率为 31.9%(95%置信区间[CI]为 30.8-33.0%),男性为 31.9%,女性为 4.8%(95%CI 为 4.3-5.3%)。
SUA 的参考范围为男性 4.0 至 9.2mg/100ml,女性 2.8 至 6.9mg/100ml。男性高尿酸血症的患病率为 31.9%,女性为 4.8%。如今,SUA 的参考范围和高尿酸血症的患病率更新,可能用于指导实验室和与 SUA 相关疾病的筛查。